📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nucleis

1.1 - Company Overview

Nucleis Logo

Nucleis

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of radiopharmaceutical drugs, manufacturing and distributing generic radiopharmaceuticals for clinical oncology, cardiology, neurology, infectious and inflammatory diseases. It aims to develop new diagnostic tools, support innovative therapies, and distributes radiopharmaceutical drugs dedicated to Positron Emission.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nucleis

VaLogic Logo

VaLogic

HQ: United States Website
  • Description: Provider of facility management solutions for pharma, biotech, and life sciences, delivering GxP compliance services (calibration, commissioning, qualification, validation, environmental monitoring), CQV, GMP environmental monitoring (air, surface, water, lab gases), cleanroom and biosafety cabinet certification, comprehensive calibration, and the LogiPoint continuous monitoring system for critical environments and equipment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VaLogic company profile →
CPH Logo

CPH

HQ: Switzerland Website
  • Description: Provider of chemical manufacturing and paper and packaging products for the chemical industries, serving the chemistry, paper, and packaging sectors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CPH company profile →
Cardinal Group Logo

Cardinal Group

HQ: United States Website
  • Description: Provider of project management and building practitioner services and solutions focused on delivering pharmaceutical and biotechnology construction projects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardinal Group company profile →
Inclinix Logo

Inclinix

HQ: United States Website
  • Description: Provider of customized Phase I-IV clinical trial enrollment solutions for pharmaceutical, biotechnology, and medical device organizations. A division of Inclinix-PMG Holdings, Inc., Inclinix combines the sites of PMG Research Inc. with premier patient recruitment solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inclinix company profile →
Pharmaceutics International Logo

Pharmaceutics International

HQ: United States Website
  • Description: Provider of science-driven contract development and manufacturing services, offering formulation development and clinical trial manufacturing for drugs and biologics; solubility/bioavailability enhancement; lyophilization formulation and cycle development with GMP scale-up; fill-finish development and aseptic fill-finish for vials, syringes, and cartridges; and ready-to-use 3mL cartridges for consistent delivery of high-viscosity, high concentration injectables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmaceutics International company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nucleis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nucleis

2.2 - Growth funds investing in similar companies to Nucleis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nucleis

4.2 - Public trading comparable groups for Nucleis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nucleis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nucleis

What does Nucleis do?

Nucleis is a provider of radiopharmaceutical drugs, manufacturing and distributing generic radiopharmaceuticals for clinical oncology, cardiology, neurology, infectious and inflammatory diseases. It aims to develop new diagnostic tools, support innovative therapies, and distributes radiopharmaceutical drugs dedicated to Positron Emission.

Who are Nucleis's competitors?

Nucleis's competitors and similar companies include VaLogic, CPH, Cardinal Group, Inclinix, and Pharmaceutics International.

Where is Nucleis headquartered?

Nucleis is headquartered in Belgium.

How many employees does Nucleis have?

Nucleis has 1,000 employees 🔒.

When was Nucleis founded?

Nucleis was founded in 2010 🔒.

What sector and industry vertical is Nucleis in?

Nucleis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nucleis

Who are the top strategic acquirers in Nucleis's sector and industry

Top strategic M&A buyers and acquirers in Nucleis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nucleis?

Top strategic M&A buyers groups and sectors for Nucleis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nucleis's sector and industry vertical

Which are the top PE firms investing in Nucleis's sector and industry vertical?

Top PE firms investing in Nucleis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nucleis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nucleis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nucleis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nucleis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nucleis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nucleis?

The key public trading comparables and valuation benchmarks for Nucleis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nucleis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nucleis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nucleis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nucleis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nucleis's' sector and industry vertical?

Access recent funding rounds and capital raises in Nucleis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nucleis